Neutropenic sepsis is a potentially fatal complication for patients receiving systemic anti-cancer treatment (SACT). Mortality rates range between 2–21% among adults, and the use of aggressive intravenous antibiotics shows a significant reduction in both morbidity and mortality. The National Institute of Health and Care Excellence (NICE) guidance and local policy state that all patients who present to hospital as unwell post-chemotherapy should receive antibiotics within 1 hour. We aimed to reduce the presentation to antibiotics time among this group of patients and fundamentally improve patient safety and outcomes.
展开▼
